Abstract:Abstract BACKGROUND AND AIMS Higher mean corpuscular volume (MCV), a measure of the average size of the circulating erythrocyte used for differential diagnosis of anemia or for monitoring macrocytosis, is associated with higher mortality in various clinical settings including in patients (pts) with kidney failure; however, results are not consistent and a study from Japan (Honda et al. Low rather than high mean corpuscular volume is associated with mortality in Japanese patients under hemodialysis. Sci Rep. 2020; 10(1): 15 663) found that low MCV associated with mortality in 8571 hemodialysis pts (mean age 62.5 ± 12.7 years, 37.2% female, median MCV 96.1 fL) pts. We investigated the relationship between MCV with all-cause and cardiovascular mortality in two cohorts of kidney failure pts from China and Sweden. METHOD In 731 incident Chinese peritoneal dialysis pts (median age 50 years, 57% males) and 404 Swedish kidney failure pts (median age 56 years, 62% males), baseline MCV and other biochemical and metabolic biomarkers were analysed in relation to mortality during follow-up period of up to 5 years. All-cause and cardiovascular disease (CVD) mortality risk were analysed with competing-risk regression models with transplantation as competing risk adjusting for age, sex, smoking, diabetes, serum albumin, hemoglobulin and calendar year. RESULTS Chinese pts were significantly younger (P < 0.01) and had lower body mass index (P < 0.01) and Framingham risk score (P < 0.01) than Swedish pts while gender distribution was similar. In univariate analysis, MCV was associated with body mass index (P < 0.01) and mean arterial blood pressure (P < 0.01) in both cohorts. ‘Chinese pts’: During median 3.6 years of follow-up, all-cause mortality rate was 16%, and 52 (46%) of 111 deaths were caused by CVD. Low MCV (<94 fL) was associated with significantly higher all-cause [Fig. 1A; sub-hazard ratio, sHR (95% CI) 2.15 (1.14–4.06)] but not CVD mortality (Fig. 2A) when adjusting for all confounders. ‘Swedish pts’: During median 2.1 years of follow-up, all-cause mortality rate was 30%, and 53 (44%) of the 120 deaths were caused by CVD. In contrast to the Chinese cohort, pts low MCV (<94 fL) was associated with lower both all-cause [Fig. 1B; sHR 0.62 (0.39–0.97)] and CVD mortality [Fig. 2B; sHR 0.49 (0.26–0.94)] when adjusting for all confounders. CONCLUSION In Chinese kidney failure pts low MCV was associated with higher all-cause mortality risk while in Swedish kidney failure pts low MCV was associated with pts lower all-cause and CVD mortality risk, independently of all confounders. Further studies are needed to explore if this difference may reflect regional differences in factors affecting MCV.

There is No Association of Serum Vitamin B Levels with All-Cause and Cardiovascular Mortality in Hemodialysis Patients

Association of serum vitamin B levels with all-cause and cardiovascular mortality in hemodialysis patients

Vitamin D Status and Mortality Risk among Patients on Dialysis: a Systematic Review and Meta-Analysis of Observational Studies.

Association of Serum Vitamin B6 with All-Cause and Cause-Specific Mortality in a Prospective Study

Effects of serum magnesium level on mortality in maintenance hemodialysis patients

Hemoglobin variability and all-cause mortality in hemodialysis patients: A systematic review and meta-analysis.

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

MO673: Association of Mean Corpuscular Volume with Mortality in Kidney Failure Patients: Opposite Findings in Chinese and Swedish Kidney Failure Patients

Comprehensive assessment on the association of dietary vitamins with all-cause and cardiovascular mortality among individuals with prediabetes: evidence from NHANES 1999–2018

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

The origin of vitamin B12 levels and risk of all-cause, cardiovascular and cancer specific mortality: a systematic review and dose-response meta-analysis

Long‐term Predialysis Blood Pressure Variability and Outcomes in Hemodialysis Patients

Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients

Relationship Between Serum Bilirubin Levels and Mortality in Patients on Peritoneal Dialysis

Water-Soluble Vitamins Status in Patients Undergoing Maintenance Hemodialysis

Association of Serum Magnesium Level with All-Cause Mortality in Maintenance Hemodialysis Patients

Relationship Between Serum Indirect Bilirubin Levels and Cardiovascular Events and All-Cause Mortality in Maintenance Hemodialysis Patients

Association between serum vitamin B12 and risk of all-cause mortality in elderly adults: a prospective cohort study

Relationship between plasma levels of homocysteine and the related B vitamins in patients with hemodialysis adequacy or inadequacy

Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing.

Free 25-Vitamin D is Correlated with Cardiovascular Events in Prevalent Hemodialysis Patients but Not with Markers of Renal Mineral Bone Disease.